| Sarah Fishbein, RN, BSN | |
|
10330 Se 32nd Ave Ste 325, Milwaukie, OR 97222-6656 | |
| (503) 416-1960 | |
| (503) 416-1959 |
| Full Name | Sarah Fishbein |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 10330 Se 32nd Ave Ste 325, Milwaukie, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023615457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 10015065 (Oregon) | Primary |
| Entity Name | Neighborhood Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174820815 PECOS PAC ID: 8426227893 Enrollment ID: O20110802000211 |
News Archive
About 25 percent of Americans experience acute insomnia each year, but about 75 percent of these individuals recover without developing persistent poor sleep or chronic insomnia, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania which will be presented Monday at SLEEP 2018, the 32nd Annual Meeting of the Associated Professional Sleep Societies LLC.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
Ikonisys, Inc., a leading provider of next-generation, cell-based diagnostic solutions, announced today that the United States Patent and Trademark Office has issued the company United States Patent No. 7,660,454 entitled "Process for identifying FISH signals."
In a new study led by the Immune Systems Biology research group of the LIH Department of Infection and Immunity, researchers adopted a holistic machine-learning approach to elucidate how the interactions between neuronal mitochondria can serve as a powerful tool to distinguish nerve cells from Parkinson's patients from those belonging to healthy subjects, thereby providing new insights in the pathogenesis, diagnosis and treatment of this neurodegenerative disorder.
In the current issue of PLoS One, researchers show how a poorly understood and previously unsuspected mechanism may be the key to understanding how life-style associated forms of oxidative stress, such as exposure to cigarette smoke, damage cells in the lungs.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Fishbein, RN, BSN 10330 Se 32nd Ave Ste 325, Milwaukie, OR 97222-6656 Ph: (503) 416-1960 | Sarah Fishbein, RN, BSN 10330 Se 32nd Ave Ste 325, Milwaukie, OR 97222-6656 Ph: (503) 416-1960 |
News Archive
About 25 percent of Americans experience acute insomnia each year, but about 75 percent of these individuals recover without developing persistent poor sleep or chronic insomnia, according to a study from researchers at the Perelman School of Medicine at the University of Pennsylvania which will be presented Monday at SLEEP 2018, the 32nd Annual Meeting of the Associated Professional Sleep Societies LLC.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
Ikonisys, Inc., a leading provider of next-generation, cell-based diagnostic solutions, announced today that the United States Patent and Trademark Office has issued the company United States Patent No. 7,660,454 entitled "Process for identifying FISH signals."
In a new study led by the Immune Systems Biology research group of the LIH Department of Infection and Immunity, researchers adopted a holistic machine-learning approach to elucidate how the interactions between neuronal mitochondria can serve as a powerful tool to distinguish nerve cells from Parkinson's patients from those belonging to healthy subjects, thereby providing new insights in the pathogenesis, diagnosis and treatment of this neurodegenerative disorder.
In the current issue of PLoS One, researchers show how a poorly understood and previously unsuspected mechanism may be the key to understanding how life-style associated forms of oxidative stress, such as exposure to cigarette smoke, damage cells in the lungs.
› Verified 5 days ago
Mrs. Marla E. Stasik, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4560 Se International Way Ste 100, Milwaukie, OR 97222 Phone: 971-712-6863 | |
Samantha Jay Abbott, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10330 Se 32nd Ave Ste 325, Milwaukie, OR 97222 Phone: 503-416-1960 | |
Joel Aaron Michels, F.N.P Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10505 Se 17th Ave, Suite 210, Milwaukie, OR 97222 Phone: 503-467-1271 Fax: 855-232-6902 | |
Dr. Andreana Marie-concetta Gentile, DNP, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 17070 Se Mcloughlin Blvd, Milwaukie, OR 97267 Phone: 503-305-6282 Fax: 503-908-0208 | |
Constance Cora Leben, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6400 Se Lake Rd Ste 325, Milwaukie, OR 97222 Phone: 503-786-1711 Fax: 503-786-9919 | |
Mr. William Timothy Dudley, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 17070 Se Mcloughlin Blvd, Milwaukie, OR 97267 Phone: 503-303-4000 |